Skip to content

8-KAccepted Apr 14, 4:43 PM ET

Emmaus Life Sciences Director Resigns Effective April 15, 2026

EMMAEmmaus Life Sciences, Inc.

Accepted (ET)

4:43 PM

Apr 14, 2026

Filed

Apr 14, 2026

Documents

11

Size

183.6 KB

Summary

Emmaus Life Sciences Director Resigns Effective April 15, 2026

Updated

What Happened
Emmaus Life Sciences, Inc. (EMMA) filed a Form 8-K on April 14, 2026 announcing that director Jon Kuwahara submitted his resignation on April 13, 2026, effective April 15, 2026. The filing reports the departure of a member of the company's board of directors.

Key Details

  • Company: Emmaus Life Sciences, Inc. (EMMA)
  • Filings: Form 8-K filed April 14, 2026 (Item 5.02)
  • Director: Jon Kuwahara resigned on April 13, 2026, effective April 15, 2026
  • The filing does not report an appointed replacement or other officer changes

Why It Matters
A board member resignation can affect board composition and governance oversight. For investors, this is a corporate governance update to monitor — watch for any future announcements about a replacement director, committee changes, or implications for company strategy.

AI-written summary · check the filing